Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections

Journal of Infectious Diseases

Volumn 188, Issue 3, 2003, Pages 469-479

  Naglik, Julian R ^a,d   Rodgers, Catherine A ^b   Shirlaw, Penelope J ^a   Dobbie, Jennifer L ^b   Fernandes Naglik, Lynette L ^a   Greenspan, Deborah ^c   Agabian, Nina ^c   Challacombe, Stephen J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; LYSOPHOSPHOLIPASE;

ADULT; ARTICLE; CANDIDA ALBICANS; DISEASE ASSOCIATION; ENZYME RELEASE; FEMALE; FUNGAL GENE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLB1 GENE; PLB2 GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SAP1 GENE; SAP2 GENE; SAP3 GENE; SAP4 GENE; SAP5 GENE; SAP6 GENE; SAP7 GENE; SAP8 GENE; THRUSH; VAGINA CANDIDIASIS; VIRULENCE;

ASPARTIC ENDOPEPTIDASES; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CANDIDIASIS, VULVOVAGINAL; CARRIER STATE; DNA PRIMERS; FEMALE; FUNGAL PROTEINS; GENE EXPRESSION; HUMANS; LYSOPHOSPHOLIPASE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVA; VAGINA;

EID: 0043159196     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/376536     Document Type: Article

References (50)

1. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992; 14 (Suppl 1):S148-53.
2. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann NY Acad Sci 1988; 544:547-57.
3. Monod M, Borg-von Zepelin M. Secreted proteinases and other virulence mechanisms of Candida albicans. Chem Immunol 2002; 81:114-28.
4. Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol 2001; 9:327-35.
5. Agabian N, Odds FC, Poulain D, Soll DR, White TC. Pathogenesis of invasive candidiasis. J Med Vet Mycol 1994; 32:229-37.
6. Odds FC. Candida species and virulence. ASM News 1994; 60:313-8.
7. Cutler JE. Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991; 45:187-218.
8. Banno Y, Yamada T, Nozawa Y. Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties. Sabouraudia 1985; 23:47-54.
9. Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985; 131:1217-21.
10. Hoover CI, Jantapour MJ, Newport G, Agabian N, Fisher SJ. Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene. FEMS Microbiol Lett 1998; 167:163-9.
11. Pugh D, Cawson RA. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 1977; 15:29-35.
12. Hube B, Hess D, Baker CA, Schaller M, Schafer W, Dolan JW. The role and relevance of phospholipase D1 during growth and dimorphism of Candida albicans. Microbiology 2001; 147:879-89.
13. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13:122-43.
14. Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem 1998; 273:26078-86.
15. Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63:1993-8.
16. Hube B, Naglik JR. Extracellular hydrolases. In: Calderone RA, ed. Candida and candidiasis. Washington, DC: American Society for Microbiology Press, 2002:107-22.
17. Hube B, Naglik J. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 2001; 147:1997-2005.
18. Hube B. Extracellular proteinases of human pathogenic fungi. In: Ernst JF, Schmidt A, eds. Contributions to microbiology: dimorphism in human pathogenic and apathogenic yeasts. Vol. 5. Basel: S. Karger AG, 2000:126-37.
19. Monod M, Togni G, Hube B, Sanglard D. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol Microbiol 1994; 13:357-68.
20. White TC, Agabian N. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 1995; 177:5215-21.
21. Hube B, Monod M, Schofield DA, Brown AJP, Gow NAR. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 1994; 14:87-99.
22. Schaller M, Schäfer W, Korting HC, Hube B. Differential expression of secreted aspartyl proteinases in a model of human oral candidiasis and in patient samples from the oral cavity. Mol Microbiol 1998; 29:605-15.
23. Staib P, Kretschmar M, Nichterlein T, Hof H, Morschhauser J. Differential activation of a Candida albicans virulence gene family during infection. PNAS 2000; 97:6102-7.
24. Schaller M, Korting HC, Schafer W, Bastert J, Chen W, Hube B. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidiasis. Mol Microbiol 1999; 34:169-80.
25. De Bernardis F, Arancia S, Morelli L, et al. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J Infect Dis 1999; 179:201-8.
26. Korting HC, Schaller M, Eder G, Hamm G, Bohmer U, Hube B. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother 1999; 43:2038-42.
27. Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 1999; 180:448-53.
28. Sanglard D, Hube B, Monod M, Odds FC, Gow NA. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 1997; 65:3539-46.
29. Borg-von Zepelin M, Meyer I, Thomssen R, et al. HIV-protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Derm 1999; 113:747-51.
30. Ibrahim AS, Filler SG, Sanglard D, Edwards JEJ, Hube B. Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect Immun 1998; 66:3003-5.
31. Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 1998; 28:543-54.
32. Ripeau JS, Fiorillo M, Aumont F, Belhumeur P, de Repentigny L. Evidence for differential expression of Candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice. J Infect Dis 2002; 185:1094-102.
33. Naglik JR, Newport G, White TC, et al. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 1999; 67:2482-90.
34. Hube B, Turver CJ, Odds FC, et al. Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J Med Vet Mycol 1991; 29:129-32.
35. Wright RJ, Carne A, Hieber AD, Lamont IL, Emerson GW, Sullivan PA. A second gene for a secreted aspartate proteinase in Candida albicans. J Bacteriol 1992; 174:7848-53.
36. White TC, Miyasaki SH, Agabian N. Three distinct secreted aspartyl proteinases in Candida albicans. J Bacteriol 1993; 175:6126-33.
37. Miyasaki SH, White TC, Agabian N. A fourth secreted aspartyl proteinase gene (SAP4) and a CARE2 repetitive element are located upstream of the SAP1 gene in Candida albicans. J Bacteriol 1994; 176:1702-10.
38. Monod M, Hube B, Hess D, Sanglard D. Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 1998; 144:2731-7.
39. Sugiyama Y, Nakashima S, Mirbod F, et al. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol 1999; 37:61-7.
40. Losberger C, Ernst JF. Sequence of the Candida albicans gene encoding actin. Nucleic Acids Res 1989; 17:9488.
41. Fidel PL Jr, Sobel JD. Protective immunity in experimental Candida vaginitis. Res Immunol 1998; 149:361-73.
42. Fidel PL Jr. Immunity to Candida. Oral Dis 2002; 8(Suppl 2):69-75.
43. Cobb BD, Clarkson JM. A simple procedure for optimising the polymerase chain reaction (PCR) using modified Taguchi methods. Nucleic Acids Res 1994; 22:3801-5.
44. Morrow B, Srikantha T, Soll DR. Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans. Mol Cell Biol 1992; 12:2997-3005.
45. Hellstein J, Vawter-Hugart H, Fotos P, Schmid J, Soll DR. Genetic similarity and phenotypic diversity of commensal and pathogenic strains of Candida albicans isolated from the oral cavity. J Clin Microbiol 1993; 31:3190-9.
46. Kretschmar M, Hube B, Bertsch T, et al. Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect Immun 1999; 67:6637-42.
47. Felk A, Kretschmar M, Albrecht A, et al. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect Immun 2002; 70:3689-700.
48. De Bernardis F, Chiani P, Ciccozzi M, et al. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 1999;64:466-71.
49. Ollert MW, Wende C, Gorlich M, et al. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 1995; 33:2543-49.
50. Homma M, Chibana H, Tanaka K. Induction of extracellular proteinase in Candida albicans. J Gen Microbiol 1993; 139:1187-93.